Also really enjoyed the talk by @theWittySquare presenting their impressive work on limited proteolysis mass spectrometry (LiP-MS) to identify the interacting proteins of small molecules and how they use it to obtain binding site information. (2/3) https:/
RT @NatureComms: New work from @theWittySquare et al. integrates limited proteolysis and machine learning for the proteome-wide mapping of…
RT @NatureComms: New work from @theWittySquare et al. integrates limited proteolysis and machine learning for the proteome-wide mapping of…
RT @NatureComms: New work from @theWittySquare et al. integrates limited proteolysis and machine learning for the proteome-wide mapping of…
RT @NatureComms: New work from @theWittySquare et al. integrates limited proteolysis and machine learning for the proteome-wide mapping of…
RT @NatureComms: New work from @theWittySquare et al. integrates limited proteolysis and machine learning for the proteome-wide mapping of…
RT @NatureComms: New work from @theWittySquare et al. integrates limited proteolysis and machine learning for the proteome-wide mapping of…
RT @NatureComms: New work from @theWittySquare et al. integrates limited proteolysis and machine learning for the proteome-wide mapping of…
New work from @theWittySquare et al. integrates limited proteolysis and machine learning for the proteome-wide mapping of drug protein targets and binding sites @biognosys @RolandMBruderer https://t.co/fFRblSTVxH https://t.co/6E41qH0PMP
RT @NatureComms: New work from @theWittySquare et al. integrates limited proteolysis and machine learning for the proteome-wide mapping of…
RT @NatureComms: New work from @theWittySquare et al. integrates limited proteolysis and machine learning for the proteome-wide mapping of…
RT @NatureComms: New work from @theWittySquare et al. integrates limited proteolysis and machine learning for the proteome-wide mapping of…
RT @NatureComms: New work from @theWittySquare et al. integrates limited proteolysis and machine learning for the proteome-wide mapping of…
RT @NatureComms: New work from @theWittySquare et al. integrates limited proteolysis and machine learning for the proteome-wide mapping of…
RT @NatureComms: New work from @theWittySquare et al. integrates limited proteolysis and machine learning for the proteome-wide mapping of…
RT @NatureComms: New work from @theWittySquare et al. integrates limited proteolysis and machine learning for the proteome-wide mapping of…
RT @NatureComms: New work from @theWittySquare et al. integrates limited proteolysis and machine learning for the proteome-wide mapping of…
RT @NatureComms: New work from @theWittySquare et al. integrates limited proteolysis and machine learning for the proteome-wide mapping of…
RT @NatureComms: New work from @theWittySquare et al. integrates limited proteolysis and machine learning for the proteome-wide mapping of…
RT @NatureComms: New work from @theWittySquare et al. integrates limited proteolysis and machine learning for the proteome-wide mapping of…
New work from @theWittySquare et al. integrates limited proteolysis and machine learning for the proteome-wide mapping of drug protein targets and binding sites @biognosys @RolandMBruderer https://t.co/fFRblSTVxH https://t.co/4sWIPif2k9
RT @StephanHacker2: Great paper by the groups of Lukas Reiter and @Picotti_Lab @ETH in @NatureComms. Quantitative limited proteolysis (LiP-…
RT @RolandMBruderer: I am very proud that our latest work on our LiP drug target discovery technology got published!!! @biognosys Thanks to…
RT @StephanHacker2: Great paper by the groups of Lukas Reiter and @Picotti_Lab @ETH in @NatureComms. Quantitative limited proteolysis (LiP-…
RT @StephanHacker2: Great paper by the groups of Lukas Reiter and @Picotti_Lab @ETH in @NatureComms. Quantitative limited proteolysis (LiP-…
RT @StephanHacker2: Great paper by the groups of Lukas Reiter and @Picotti_Lab @ETH in @NatureComms. Quantitative limited proteolysis (LiP-…
RT @StephanHacker2: Great paper by the groups of Lukas Reiter and @Picotti_Lab @ETH in @NatureComms. Quantitative limited proteolysis (LiP-…
Great paper by the groups of Lukas Reiter and @Picotti_Lab @ETH in @NatureComms. Quantitative limited proteolysis (LiP-Quant) to identify target proteins of small molecules in human proteomes. Interesting approach to also get an idea of the binding sites.
RT @RoyalVoxPost: #AI #Pharmacology: researchers developed a #MachineLearning method that can accurately characterize the mode of action of…
RT @RoyalVoxPost: #AI #Pharmacology: researchers developed a #MachineLearning method that can accurately characterize the mode of action of…
RT @RoyalVoxPost: #AI #Pharmacology: researchers developed a #MachineLearning method that can accurately characterize the mode of action of…
RT @emanuelvgo: A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes https://t.…
RT @emanuelvgo: A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes https://t.…
A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes https://t.co/jQwug1LADm
RT @LC_Analysis: A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes https://t…
RT @LC_Analysis: A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes https://t…
RT @LC_Analysis: A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes https://t…
RT @LC_Analysis: A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes https://t…
A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes https://t.co/GFoVUAJWUP
RT @DDNewsOnline: .@biognosys et al describe #chemoproteomic workflow combining limited #proteolysis & #MachineLearning Facilitates discov…
RT @DDNewsOnline: .@biognosys et al describe #chemoproteomic workflow combining limited #proteolysis & #MachineLearning Facilitates discov…
RT @RoyalVoxPost: #AI #Pharmacology: researchers developed a #MachineLearning method that can accurately characterize the mode of action of…
A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes https://t.co/CNXYzLyZhQ https://t.co/22emnLPcD5
RT @RolandMBruderer: I am very proud that our latest work on our LiP drug target discovery technology got published!!! @biognosys Thanks to…
RT @RolandMBruderer: I am very proud that our latest work on our LiP drug target discovery technology got published!!! @biognosys Thanks to…
RT @RolandMBruderer: I am very proud that our latest work on our LiP drug target discovery technology got published!!! @biognosys Thanks to…
A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes | Nature Communications https://t.co/jREyP2pNiK
RT @RolandMBruderer: I am very proud that our latest work on our LiP drug target discovery technology got published!!! @biognosys Thanks to…
RT @RolandMBruderer: I am very proud that our latest work on our LiP drug target discovery technology got published!!! @biognosys Thanks to…
RT @RoyalVoxPost: #AI #Pharmacology: researchers developed a #MachineLearning method that can accurately characterize the mode of action of…
RT @RoyalVoxPost: #AI #Pharmacology: researchers developed a #MachineLearning method that can accurately characterize the mode of action of…
RT @RoyalVoxPost: #AI #Pharmacology: researchers developed a #MachineLearning method that can accurately characterize the mode of action of…
RT @RoyalVoxPost: #AI #Pharmacology: researchers developed a #MachineLearning method that can accurately characterize the mode of action of…
#AI #Pharmacology: researchers developed a #MachineLearning method that can accurately characterize the mode of action of medications and identify new druggable protein targets. The technique could facilitate the discovery of new therapeutic compounds - ht
RT @RolandMBruderer: I am very proud that our latest work on our LiP drug target discovery technology got published!!! @biognosys Thanks to…
RT @RolandMBruderer: I am very proud that our latest work on our LiP drug target discovery technology got published!!! @biognosys Thanks to…
RT @RolandMBruderer: I am very proud that our latest work on our LiP drug target discovery technology got published!!! @biognosys Thanks to…
RT @RolandMBruderer: I am very proud that our latest work on our LiP drug target discovery technology got published!!! @biognosys Thanks to…
RT @Picotti_Lab: In collaboration with @biognosys we (@theWittySquare) developed the LiP-MS technique further to confidently identify drug…
A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes https://t.co/ujaUGG0Wrm #MachineLearning #NatureJournal #AI https://t.co/A4fl2YYYuJ
RT @RolandMBruderer: I am very proud that our latest work on our LiP drug target discovery technology got published!!! @biognosys Thanks to…
RT @Picotti_Lab: In collaboration with @biognosys we (@theWittySquare) developed the LiP-MS technique further to confidently identify drug…
RT @Picotti_Lab: In collaboration with @biognosys we (@theWittySquare) developed the LiP-MS technique further to confidently identify drug…
In collaboration with @biognosys we (@theWittySquare) developed the LiP-MS technique further to confidently identify drug target interactions and estimate EC50 values in complex eukaryotic proteomes. Read more about LiP-Quant here @NatureComms : https://
RT @RolandMBruderer: I am very proud that our latest work on our LiP drug target discovery technology got published!!! @biognosys Thanks to…
Derisking drug discovery by decoding one of the toughest challenges of drug specificity and selectivity with next-gen #proteomics and #LiPTargetID Congrats to the @biognosys team and our collaborators at @ETH @Bayer and @BASF for an impactful @NatureComms
RT @RolandMBruderer: I am very proud that our latest work on our LiP drug target discovery technology got published!!! @biognosys Thanks to…
RT @theWittySquare: It was a pleasure for me too to work with @biognosys @RolandMBruderer
It was a pleasure for me too to work with @biognosys @RolandMBruderer
A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes https://t.co/kY07wih9Mz #nature #MassSpecPub https://t.co/nzsH7qkwwJ
I am very proud that our latest work on our LiP drug target discovery technology got published!!! @biognosys Thanks to the @Picotti_Lab and @theWittySquare for the powerful collaboration! https://t.co/vg95xvy8Xv https://t.co/plUSJK57rG